Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma

Kyung Sun Lee, Seoung Ju Park, So Ri Kim, Kyung-Hoon Min, Sun Mi Jin, Kamal D. Puri, Yong Chul Lee

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background: Bronchial asthma is characterized by inflammation of the airways, which is usually accompanied by increased vascular permeability, resulting in plasma exudation. Vascular endothelial growth factor (VEGF) has been implicated in contributing to asthmatic tissue edema through its effect on vascular permeability. Many cellular responses of VEGF are regulated by the lipid products of phosphoinositide 3-kinase (PI3K). However, the effect of PI3K catalytic subunit p110δ on VEGF-mediated signaling is unknown. Recently, an isoform-specific small molecule inhibitor, IC87114, which is selective for p110δ catalytic activity, has been identified. Objective: We have sought to investigate the role of PI3K-δ, more specifically in the increase of vascular permeability. Methods: Female BALB/c mice were sensitized and challenged with ovalbumin. We have investigated the effect of IC87114 on airway inflammation, TH2 cytokines expression, airway hyperresponsiveness, plasma extravasation, hypoxia-inducible factor 1α expression, and VEGF expression in a murine model of asthma. Results: Our current study has revealed that IC87114 reduces antigen-induced airway infiltration of inflammatory cells, secretion of TH2 cytokines in lungs, airway hyperresponsiveness, and vascular permeability. Moreover, we have found that inhibition of p110δ reduces ovalbumin-induced upregulation of VEGF level. Conclusion: These results suggest that PI3K-δ inhibitor attenuates antigen-induced airway inflammation and hyperresponsiveness by preventing vascular leakage in mice. Clinical implications: These findings provide a crucial molecular mechanism for the potential role of PI3K-δ in asthma and other airway inflammatory disorders.

Original languageEnglish
Pages (from-to)403-409
Number of pages7
JournalJournal of Allergy and Clinical Immunology
Volume118
Issue number2
DOIs
Publication statusPublished - 2006 Jan 1
Externally publishedYes

Fingerprint

1-Phosphatidylinositol 4-Kinase
Capillary Permeability
Vascular Endothelial Growth Factor A
Asthma
Ovalbumin
Inflammation
Cytokines
Antigens
Hypoxia-Inducible Factor 1
Blood Vessels
Edema
Catalytic Domain
Protein Isoforms
Up-Regulation
Lipids
Lung
IC 87114

Keywords

  • Airway
  • PI3K-δ
  • vascular permeability
  • VEGF

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma. / Lee, Kyung Sun; Park, Seoung Ju; Kim, So Ri; Min, Kyung-Hoon; Jin, Sun Mi; Puri, Kamal D.; Lee, Yong Chul.

In: Journal of Allergy and Clinical Immunology, Vol. 118, No. 2, 01.01.2006, p. 403-409.

Research output: Contribution to journalArticle

Lee, Kyung Sun ; Park, Seoung Ju ; Kim, So Ri ; Min, Kyung-Hoon ; Jin, Sun Mi ; Puri, Kamal D. ; Lee, Yong Chul. / Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma. In: Journal of Allergy and Clinical Immunology. 2006 ; Vol. 118, No. 2. pp. 403-409.
@article{64a57a0f9823462d9c9e70107e869b20,
title = "Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma",
abstract = "Background: Bronchial asthma is characterized by inflammation of the airways, which is usually accompanied by increased vascular permeability, resulting in plasma exudation. Vascular endothelial growth factor (VEGF) has been implicated in contributing to asthmatic tissue edema through its effect on vascular permeability. Many cellular responses of VEGF are regulated by the lipid products of phosphoinositide 3-kinase (PI3K). However, the effect of PI3K catalytic subunit p110δ on VEGF-mediated signaling is unknown. Recently, an isoform-specific small molecule inhibitor, IC87114, which is selective for p110δ catalytic activity, has been identified. Objective: We have sought to investigate the role of PI3K-δ, more specifically in the increase of vascular permeability. Methods: Female BALB/c mice were sensitized and challenged with ovalbumin. We have investigated the effect of IC87114 on airway inflammation, TH2 cytokines expression, airway hyperresponsiveness, plasma extravasation, hypoxia-inducible factor 1α expression, and VEGF expression in a murine model of asthma. Results: Our current study has revealed that IC87114 reduces antigen-induced airway infiltration of inflammatory cells, secretion of TH2 cytokines in lungs, airway hyperresponsiveness, and vascular permeability. Moreover, we have found that inhibition of p110δ reduces ovalbumin-induced upregulation of VEGF level. Conclusion: These results suggest that PI3K-δ inhibitor attenuates antigen-induced airway inflammation and hyperresponsiveness by preventing vascular leakage in mice. Clinical implications: These findings provide a crucial molecular mechanism for the potential role of PI3K-δ in asthma and other airway inflammatory disorders.",
keywords = "Airway, PI3K-δ, vascular permeability, VEGF",
author = "Lee, {Kyung Sun} and Park, {Seoung Ju} and Kim, {So Ri} and Kyung-Hoon Min and Jin, {Sun Mi} and Puri, {Kamal D.} and Lee, {Yong Chul}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.jaci.2006.04.041",
language = "English",
volume = "118",
pages = "403--409",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma

AU - Lee, Kyung Sun

AU - Park, Seoung Ju

AU - Kim, So Ri

AU - Min, Kyung-Hoon

AU - Jin, Sun Mi

AU - Puri, Kamal D.

AU - Lee, Yong Chul

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Background: Bronchial asthma is characterized by inflammation of the airways, which is usually accompanied by increased vascular permeability, resulting in plasma exudation. Vascular endothelial growth factor (VEGF) has been implicated in contributing to asthmatic tissue edema through its effect on vascular permeability. Many cellular responses of VEGF are regulated by the lipid products of phosphoinositide 3-kinase (PI3K). However, the effect of PI3K catalytic subunit p110δ on VEGF-mediated signaling is unknown. Recently, an isoform-specific small molecule inhibitor, IC87114, which is selective for p110δ catalytic activity, has been identified. Objective: We have sought to investigate the role of PI3K-δ, more specifically in the increase of vascular permeability. Methods: Female BALB/c mice were sensitized and challenged with ovalbumin. We have investigated the effect of IC87114 on airway inflammation, TH2 cytokines expression, airway hyperresponsiveness, plasma extravasation, hypoxia-inducible factor 1α expression, and VEGF expression in a murine model of asthma. Results: Our current study has revealed that IC87114 reduces antigen-induced airway infiltration of inflammatory cells, secretion of TH2 cytokines in lungs, airway hyperresponsiveness, and vascular permeability. Moreover, we have found that inhibition of p110δ reduces ovalbumin-induced upregulation of VEGF level. Conclusion: These results suggest that PI3K-δ inhibitor attenuates antigen-induced airway inflammation and hyperresponsiveness by preventing vascular leakage in mice. Clinical implications: These findings provide a crucial molecular mechanism for the potential role of PI3K-δ in asthma and other airway inflammatory disorders.

AB - Background: Bronchial asthma is characterized by inflammation of the airways, which is usually accompanied by increased vascular permeability, resulting in plasma exudation. Vascular endothelial growth factor (VEGF) has been implicated in contributing to asthmatic tissue edema through its effect on vascular permeability. Many cellular responses of VEGF are regulated by the lipid products of phosphoinositide 3-kinase (PI3K). However, the effect of PI3K catalytic subunit p110δ on VEGF-mediated signaling is unknown. Recently, an isoform-specific small molecule inhibitor, IC87114, which is selective for p110δ catalytic activity, has been identified. Objective: We have sought to investigate the role of PI3K-δ, more specifically in the increase of vascular permeability. Methods: Female BALB/c mice were sensitized and challenged with ovalbumin. We have investigated the effect of IC87114 on airway inflammation, TH2 cytokines expression, airway hyperresponsiveness, plasma extravasation, hypoxia-inducible factor 1α expression, and VEGF expression in a murine model of asthma. Results: Our current study has revealed that IC87114 reduces antigen-induced airway infiltration of inflammatory cells, secretion of TH2 cytokines in lungs, airway hyperresponsiveness, and vascular permeability. Moreover, we have found that inhibition of p110δ reduces ovalbumin-induced upregulation of VEGF level. Conclusion: These results suggest that PI3K-δ inhibitor attenuates antigen-induced airway inflammation and hyperresponsiveness by preventing vascular leakage in mice. Clinical implications: These findings provide a crucial molecular mechanism for the potential role of PI3K-δ in asthma and other airway inflammatory disorders.

KW - Airway

KW - PI3K-δ

KW - vascular permeability

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=33746581368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746581368&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2006.04.041

DO - 10.1016/j.jaci.2006.04.041

M3 - Article

C2 - 16890765

AN - SCOPUS:33746581368

VL - 118

SP - 403

EP - 409

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -